Peptyde Bio

St Louis, United States

Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.

$1.2M raised

Nov 2022

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Peptyde Bio raised?

Peptyde Bio has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2022.

Who are Peptyde Bio's investors?

Peptyde Bio's investors include BioGenerator, Wells Fargo Innovation Incubator, QRM Capital, St. Louis Arch Angels, Danforth Technology Company.

Where is Peptyde Bio headquartered?

Peptyde Bio is headquartered in St Louis, United States.

What does Peptyde Bio do?

Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.

What stage is Peptyde Bio at?

Peptyde Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2022.

MLA

"Peptyde Bio — Funding & Investors." VCBacked, November 15, 2022, https://www.vcbacked.co/company/peptyde-bio. Accessed July 3, 2026.

APA

VCBacked. (2022). Peptyde Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/peptyde-bio

Wikipedia (cite web)

{{cite web |title=Peptyde Bio — Funding & Investors |url=https://www.vcbacked.co/company/peptyde-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2022.